NCT03646526View on ClinicalTrials.gov

Bioavailability Study of Amitriptyline Hydrochloride Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 4, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Depressive Disorder
Interventions
DRUG

Amitriptyline Hydrochloride 25Mg Tablet（Hunan Dongting）

Amitriptyline Hydrochloride 25Mg Tablet（Hunan Dongting）is a generic product manufactured by Hunan Dongting Pharmaceutical Co., Ltd.

DRUG

Amitriptyline Hydrochloride 25Mg Tablet（Sandoz）

Amitriptyline Hydrochloride 25Mg Tablet（Sandoz）is a generic product manufactured by Sandoz Inc;

Trial Locations (1)

310000

The First Affiliated Hospital,ZheJiang Univercity, Hanzhou

All Listed Sponsors
collaborator

Hunan DongtingPharm.Co.Ltd

UNKNOWN

lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT03646526 - Bioavailability Study of Amitriptyline Hydrochloride Tablets | Biotech Hunter | Biotech Hunter